152 related articles for article (PubMed ID: 34452557)
1. Prognostic Significance of Tripartite Motif Containing 16 Expression in Patients with Gastric Cancer.
Afshar J; Mehrzad J; Mehrad-Majd H; Goshayeshi L; Saeidi J
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2445-2451. PubMed ID: 34452557
[TBL] [Abstract][Full Text] [Related]
2. Changes in the Expression of Long Non-Coding RNA SDMGC and Its Target Gene, TRIM16, in Patients with Gastric Cancer.
Seifi Inallou M; Safaralizadeh R; Rajabi A; Hosseinpourfeizi M; Haghi M
J Gastrointest Cancer; 2023 Mar; 54(1):44-50. PubMed ID: 34978663
[TBL] [Abstract][Full Text] [Related]
3. TRIM58 suppresses the tumor growth in gastric cancer by inactivation of β-catenin signaling via ubiquitination.
Liu X; Long Z; Cai H; Yu S; Wu J
Cancer Biol Ther; 2020; 21(3):203-212. PubMed ID: 31747856
[No Abstract] [Full Text] [Related]
4. Decreased expression of TRIM3 gene predicts a poor prognosis in gastric cancer.
Farhadi J; Goshayeshi L; Motavalizadehkakhky A; Mehrzad J; Mehrad-Majd H
J Gastrointest Cancer; 2022 Mar; 53(1):179-186. PubMed ID: 33415720
[TBL] [Abstract][Full Text] [Related]
5. TRIM3 and TRIM16 as potential tumor suppressors in breast cancer patients.
Roshanazadeh MR; Adelipour M; Sanaei A; Chenane H; Rashidi M
BMC Res Notes; 2022 Sep; 15(1):312. PubMed ID: 36180926
[TBL] [Abstract][Full Text] [Related]
6. TRIM16 overexpression inhibits the metastasis of colorectal cancer through mediating Snail degradation.
Ruan L; Liu W; Yang Y; Chu Z; Yang C; Yang T; Sun J
Exp Cell Res; 2021 Sep; 406(1):112735. PubMed ID: 34265287
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of TRIM29 expression in patients with gastric cancer.
Farhadi J; Mehrzad J; Mehrad-Majd H; Motavalizadehkakhky A
Gastroenterol Hepatol Bed Bench; 2022; 15(2):131-138. PubMed ID: 35845310
[TBL] [Abstract][Full Text] [Related]
8. Clinical Significance of TRIM44 Expression in Patients with Gastric Cancer.
Goshayeshi L; Afshar J; Mehrad-Majd H
Asian Pac J Cancer Prev; 2022 May; 23(5):1725-1731. PubMed ID: 35633558
[TBL] [Abstract][Full Text] [Related]
9. Tripartite motif containing 62 is a novel prognostic marker and suppresses tumor metastasis via c-Jun/Slug signaling-mediated epithelial-mesenchymal transition in cervical cancer.
Liu TY; Chen J; Shang CL; Shen HW; Huang JM; Liang YC; Wang W; Zhao YH; Liu D; Shu M; Guo LY; Hu Z; Yao SZ
J Exp Clin Cancer Res; 2016 Oct; 35(1):170. PubMed ID: 27793172
[TBL] [Abstract][Full Text] [Related]
10. JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis.
Chen JJ; Ren YL; Shu CJ; Zhang Y; Chen MJ; Xu J; Li J; Li AP; Chen DY; He JD; Shu YQ; Zhou JW
J Exp Clin Cancer Res; 2020 Jun; 39(1):118. PubMed ID: 32576271
[TBL] [Abstract][Full Text] [Related]
11. TRIM16 E121D variant affects the risk and prognosis of hepatocellular carcinoma by modulating the Wnt/β-catenin pathway.
Li S; Wang J; Chen H; Hou J; Shen T; Li J; Zhou B; Zhang B; Liu H; Jiang DK
Mol Carcinog; 2023 Nov; 62(11):1686-1699. PubMed ID: 37477507
[TBL] [Abstract][Full Text] [Related]
12. RASSF6-TRIM16 axis promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma.
Zheng L; Zhao Z; Rong L; Xue L; Song Y
J Genet Genomics; 2019 Oct; 46(10):477-488. PubMed ID: 31812473
[TBL] [Abstract][Full Text] [Related]
13. TRIM32 promotes cell proliferation and invasion by activating β-catenin signalling in gastric cancer.
Wang C; Xu J; Fu H; Zhang Y; Zhang X; Yang D; Zhu Z; Wei Z; Hu Z; Yan R; Cai Q
J Cell Mol Med; 2018 Oct; 22(10):5020-5028. PubMed ID: 30079558
[TBL] [Abstract][Full Text] [Related]
14. CircPTK2 inhibits cell cisplatin (CDDP) resistance by targeting miR-942/TRIM16 axis in non-small cell lung cancer (NSCLC).
Wang Y; Wu Y; Xie S
Bioengineered; 2022 Feb; 13(2):3651-3664. PubMed ID: 35230201
[TBL] [Abstract][Full Text] [Related]
15. Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.
Li G; Xu J; Wang Z; Yuan Y; Li Y; Cai S; He Y
J Cancer Res Clin Oncol; 2015 Mar; 141(3):443-52. PubMed ID: 25261987
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive profiling of the TRIpartite motif family to identify pivot genes in hepatocellular carcinoma.
Wu L; Yin X; Jiang K; Yin J; Yu H; Yang L; Ma C; Yan S
Cancer Med; 2022 Apr; 11(7):1712-1731. PubMed ID: 35142083
[TBL] [Abstract][Full Text] [Related]
17. Tripartite motif 16 inhibits hepatocellular carcinoma cell migration and invasion.
Li L; Dong L; Qu X; Jin S; Lv X; Tan G
Int J Oncol; 2016 Apr; 48(4):1639-49. PubMed ID: 26892350
[TBL] [Abstract][Full Text] [Related]
18. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
Guo J; Dong B; Ji JF; Wu AW
World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
[TBL] [Abstract][Full Text] [Related]
19. Tripartite motif 31 drives gastric cancer cell proliferation and invasion through activating the Wnt/β-catenin pathway by regulating Axin1 protein stability.
Feng Q; Nie F; Gan L; Wei X; Liu P; Liu H; Zhang K; Fang Z; Wang H; Fang N
Sci Rep; 2023 Nov; 13(1):20099. PubMed ID: 37973999
[TBL] [Abstract][Full Text] [Related]
20. TRIM32 Promotes the Growth of Gastric Cancer Cells through Enhancing AKT Activity and Glucose Transportation.
Wang J; Fang Y; Liu T
Biomed Res Int; 2020; 2020():4027627. PubMed ID: 32051827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
